NT5E and glioblastoma: In conclusion, we found that CD73-positive TDEVs enriched in exosomes derived from GBM cells inhibit T-cell aerobic glycolysis, cell cycle entry and clonal proliferation systemically through an adenosine-A2AR interaction-dependent process, which indicates that treatments addressing the activity of CD73+ TDEVs have the potential to enhance ICT.